The biotech market in the United States is experiencing a rapid surge in demand for Tirzepatide APIs. This potent medication, used to treat glucose intolerance, has captured considerable attention from both consumers and healthcare professionals. As a result, numerous companies have emerged as makers of Tirzepatide APIs in the USA. Well-known Ti